March 26, 2024
Daiichi Sankyo said on March 25 that it has submitted a new drug application to Japanese regulatory authorities for its freeze-dried live attenuated measles-mumps-rubella (MMR) vaccine VN-0102/JVC-001. VN-0102/JVC-001 adds a mumps vaccine strain to the company’s freeze-dried live attenuated measles-rubella...read more